tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Ratios

Compare
500 Followers

Supernus Pharmaceuticals Ratios

SUPN's free cash flow for Q4 2024 was $0.85. For the 2024 fiscal year, SUPN's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.35 1.70 1.07 1.91 2.57
Quick Ratio
2.16 1.43 0.93 1.63 2.37
Cash Ratio
0.24 0.26 0.14 0.65 1.18
Solvency Ratio
0.46 0.24 0.18 0.10 0.19
Operating Cash Flow Ratio
0.59 0.38 0.17 0.40 0.56
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.29 17.55 26.01
Net Current Asset Value
$ 353.73M$ 136.96M$ -82.15M$ -271.71M$ -128.83M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.26 0.25 0.26
Debt-to-Equity Ratio
0.03 0.05 0.49 0.52 0.52
Debt-to-Capital Ratio
0.03 0.04 0.33 0.34 0.34
Long-Term Debt-to-Capital Ratio
0.03 0.00 0.00 0.32 0.33
Financial Leverage Ratio
1.32 1.39 1.92 2.07 2.02
Debt Service Coverage Ratio
0.00 36.68 0.38 3.57 5.87
Interest Coverage Ratio
0.00 -2.18 9.52 3.67 7.31
Debt to Market Cap
0.01 0.00 0.21 0.25 0.29
Interest Debt Per Share
0.62 0.81 8.29 8.36 7.87
Net Debt to EBITDA
-0.20 -0.37 2.25 1.68 0.48
Profitability Margins
Gross Profit Margin
88.23%86.21%86.93%87.05%89.92%
EBIT Margin
14.79%0.85%10.16%16.66%36.97%
EBITDA Margin
26.94%14.82%23.00%22.28%40.82%
Operating Profit Margin
12.34%-0.87%10.09%14.84%33.38%
Pretax Profit Margin
14.79%0.46%9.10%12.62%32.41%
Net Profit Margin
11.16%0.22%9.10%9.21%24.39%
Continuous Operations Profit Margin
11.16%0.22%9.10%9.21%24.39%
Net Income Per EBT
75.47%47.53%99.95%73.01%75.28%
EBT Per EBIT
119.84%-52.55%90.25%85.06%97.09%
Return on Assets (ROA)
5.40%0.10%3.57%3.16%8.44%
Return on Equity (ROE)
7.13%0.14%6.85%6.55%17.04%
Return on Capital Employed (ROCE)
7.59%-0.53%6.63%6.26%13.80%
Return on Invested Capital (ROIC)
5.69%-0.25%4.73%4.53%10.28%
Return on Tangible Assets
10.13%0.23%6.88%6.79%11.96%
Earnings Yield
3.71%0.08%3.17%3.45%9.59%
Efficiency Ratios
Receivables Turnover
4.66 4.21 4.03 3.89 3.69
Payables Turnover
16.98 42.66 8.27 8.04 8.53
Inventory Turnover
1.43 1.08 0.95 0.87 1.09
Fixed Asset Turnover
57.32 14.29 43.98 34.19 13.76
Asset Turnover
0.48 0.48 0.39 0.34 0.35
Working Capital Turnover Ratio
2.22 4.88 4.01 1.73 1.49
Cash Conversion Cycle
311.24 415.30 429.49 466.38 392.28
Days of Sales Outstanding
78.36 86.61 90.53 93.76 98.81
Days of Inventory Outstanding
254.37 337.24 383.08 417.99 336.24
Days of Payables Outstanding
21.49 8.56 44.12 45.37 42.77
Operating Cycle
332.73 423.85 473.61 511.75 435.05
Cash Flow Ratios
Operating Cash Flow Per Share
3.12 2.04 2.18 2.39 2.63
Free Cash Flow Per Share
3.11 2.03 2.17 2.36 2.56
CapEx Per Share
0.01 0.01 <0.01 0.04 0.07
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 0.98 0.98
Dividend Paid and CapEx Coverage Ratio
237.17 201.61 283.56 62.16 40.13
Capital Expenditure Coverage Ratio
237.17 201.61 283.56 62.16 40.13
Operating Cash Flow Coverage Ratio
5.02 2.68 0.27 0.30 0.35
Operating Cash Flow to Sales Ratio
0.26 0.18 0.18 0.22 0.27
Free Cash Flow Yield
8.59%7.00%6.08%8.08%10.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
26.97 1.20K 31.53 28.98 10.43
Price-to-Sales (P/S) Ratio
3.01 2.60 2.87 2.67 2.54
Price-to-Book (P/B) Ratio
1.92 1.71 2.16 1.90 1.78
Price-to-Free Cash Flow (P/FCF) Ratio
11.64 14.28 16.44 12.38 9.81
Price-to-Operating Cash Flow Ratio
11.59 14.21 16.39 12.18 9.57
Price-to-Earnings Growth (PEG) Ratio
<0.01 -12.25 2.65 -0.50 0.90
Price-to-Fair Value
1.92 1.71 2.16 1.90 1.78
Enterprise Value Multiple
10.98 17.16 14.72 13.67 6.71
EV to EBITDA
10.98 17.16 14.72 13.67 6.71
EV to Sales
2.96 2.54 3.39 3.05 2.74
EV to Free Cash Flow
11.43 13.98 19.41 14.11 10.56
EV to Operating Cash Flow
11.38 13.91 19.34 13.89 10.30
Tangible Book Value Per Share
7.20 3.75 1.24 -1.63 4.27
Shareholders’ Equity Per Share
18.80 16.90 16.51 15.36 14.16
Tax and Other Ratios
Effective Tax Rate
0.25 0.52 <0.01 0.27 0.25
Revenue Per Share
12.01 11.14 12.43 10.92 9.89
Net Income Per Share
1.34 0.02 1.13 1.01 2.41
Tax Burden
0.75 0.48 1.00 0.73 0.75
Interest Burden
1.00 0.53 0.90 0.76 0.88
Research & Development to Revenue
0.16 0.15 0.11 0.16 0.15
SG&A to Revenue
0.14 0.39 0.16 0.18 0.13
Stock-Based Compensation to Revenue
0.04 0.04 0.03 0.03 0.03
Income Quality
2.33 84.41 1.92 2.38 1.09
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis